Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial

BACKGROUND: Patients with high-risk prostate cancer are at increased risk of lymph node metastasis and are thought to benefit from whole pelvis radiotherapy (WPRT). There has been recent interest in the use of hypofractionated radiotherapy in treating prostate cancer. However, toxicity and cancer ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendez, Lucas C., Arifin, Andrew J., Bauman, Glenn S., Velker, Vikram M., Ahmad, Belal, Lock, Michael, Venkatesan, Varagur M., Sexton, Tracy L., Rodrigues, George B., Chen, Jeff, Schaly, Bryan, Warner, Andrew, D’Souza, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547418/
https://www.ncbi.nlm.nih.gov/pubmed/33036579
http://dx.doi.org/10.1186/s12885-020-07490-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547418/
https://www.ncbi.nlm.nih.gov/pubmed/33036579
http://dx.doi.org/10.1186/s12885-020-07490-0

Ejemplares similares